TrialCancer science2016

Dose modifications in Asian cancer patients with hepatic dysfunction receiving weekly docetaxel: A prospective pharmacokinetic and safety study.

Nicholas Li-Xun Syn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.